Interpretation of chloroquine pharmacokinetic data

[1]  P. Geusens,et al.  Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis , 1992, European Journal of Clinical Pharmacology.

[2]  D. Cutler,et al.  Apparent dose-dependence of chloroquine pharmacokinetics due to limited assay sensitivity and short sampling times , 2004, European Journal of Clinical Pharmacology.

[3]  Y. Bergqvist,et al.  The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects , 2004, European Journal of Clinical Pharmacology.

[4]  R. Day,et al.  Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques. , 1992, Journal of pharmaceutical sciences.

[5]  R. Day,et al.  Bioavailability of hydroxychloroquine tablets in healthy volunteers. , 1989, British journal of clinical pharmacology.

[6]  R. Day,et al.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers. , 1988, British journal of clinical pharmacology.

[7]  J. McElnay,et al.  Investigation of chloroquine binding to plastic materials , 1986 .

[8]  Ö. Ericsson,et al.  Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.

[9]  B. Beermann,et al.  Disposition of chloroquine in man after single intravenous and oral doses. , 1983, British journal of clinical pharmacology.

[10]  J. Jensen,et al.  Characteristics of chloroquine binding to glass and plastic. , 1983, The American journal of tropical medicine and hygiene.